Latest: FDA Approves New Biosimilar for Oncology Treatment

Mount Sinai Researchers Use AI and Lab Data to Predict Genetic Disease Risk

0 Mins
What You Should Know: – Researchers at the Icahn School of Medicine at Mount Sinai have developed a new method using artificial intelligence (AI) and routine lab tests to determine the likelihood that a patient with a rare DNA mutation will actually develop a disease. – The concept is known in genetics as penetrance. The ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago